7-chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione | 91833-31-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 7-chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione
• 英文别名: 7-Chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f][1,4]oxazepine-5(4H)thione；7-Chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f][1,4]oxazepin-5(4H)thione；7-chloro-2-(2-chloroethyl)-4-methyl-2,3-dihydropyrido[3,2-f][1,4]oxazepine-5-thione
• CAS: 91833-31-7
• 化学式: C₁₁H₁₂Cl₂N₂OS
• 分子量: 291.201
• InChiKey: ABTVIRXYTSZJEY-UHFFFAOYSA-N

物化性质

• 熔点：
  125-127 °C
• 沸点：
  415.2±55.0 °C(Predicted)
• 密度：
  1.43±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  57.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione 生成 7-Chloro-2-[2-(dimethylamino)ethyl]-4-methyl-2,3-dihydropyrido[3,2-f][1,4]oxazepine-5-thione
  参考文献：
  名称：

  摘要：

  DOI：
• 作为产物：
  描述：

  2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido<3,2-f>-1,4-oxazepin-5(H)-one hydrochloride 在 劳森试剂 、 磺酰氯 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 0.5h， 生成 7-chloro-2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione
  参考文献：
  名称：

  Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1-antihistamines

  摘要：

  A series of novel benzo- and pyrido-1,4-oxazepinones and -thiones which represents a new structural class of compounds possessing H1 antihistaminic activity was synthesized, and the SARs were evaluated. The antihistaminic activity was determined by blockade of histamine-induced lethality in guinea pigs. The sedative potential was determined by comparison of the EEG profiles of the compounds with those of known sedating and nonsedating antihistamines. Several of the compounds were shown to possess potent H1 antihistaminic activity and to be free of the cortical slowing with synchronized waves and spindling activity found in the EEG of sedative antihistamines. One compound, 2-[2-(dimethylamino)ethyl]-3,4-dihydro-4-methylpyrido[3,2-f]-1,4- oxazepine-5(2H)-thione (rocastine) is currently undergoing clinical evaluation as a nonsedating H1 antihistamine.

  DOI：

  10.1021/jm00129a026

文献信息

• Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur
  申请人：A. H. Robins Company, Inc.

  公开号：US04705853A1

  公开（公告）日：1987-11-10

  Aromatic azepinones and thiones having the formula ##STR1## wherein; A is benzene, naphthalene, quinoline or pyridine; B is oxygen or sulfur; E is oxygen, sulfur or ##STR2## n is 1, 2 or 3; Z is an amino or a heterocyclic nitrogen-containing radical; R is hydrogen, loweralkyl, cycloalkyl or phenylloweralkyl; Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracetylamino, trifluoromethyl, phenyl or phenyl substituted by one to three Y' radicals selected from halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracylamino or trifluoromethyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.

  芳香族氮杂七元酮和硫醚的化学式为##STR1##其中；A为苯、萘、喹啉或吡啶；B为氧或硫；E为氧、硫或##STR2##n为1、2或3；Z为氨基或含氮杂环的基团；R为氢、较低烷基、环烷基或苯基较低烷基；Y为卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低乙酰氨基、三氟甲基、苯基或被从卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低酰胺基或三氟甲基中选择的一个至三个Y'基团取代的苯基；具有抗组胺作用，公开了其制备方法和化学中间体。
• Intermediates useful in the preparation of fused aromatic oxazepinones,
  申请人：A. H. Robins Company, Inc.

  公开号：US04727152A1

  公开（公告）日：1988-02-23

  Chemical intermediates having the formula: ##STR1## wherein A represents an aromatic or heterocyclic ring system selected from benzene, a naphthalene, a quinoline or a pyridine in any of its four positions, any of the rings systems are optionally substituted by one or two Y radicals selected from the group consisting of halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro or trifluoromethyl; R is selected from the group consisting of loweralkyl, cycloalkyl or phenylloweralkyl wherein phenyl is optionally substituted by one or two radicals selected from halo, loweralkyl, loweralkoxy, nitro or trifluoromethyl; R.sup.4 and R.sup.5 are selected from hydrogen or loweralkyl; n is 1 or 2; X is selected from chlorine, bromine, or fluorine and E is selected from sulfur, oxygen or ##STR2## and chemical intermediates having the formula: ##STR3## wherein A, R, R.sup.4, R.sup.5, E and n are as defined above and Q is selected from the group consisting of ##STR4## wherein R.sup.3 is hydrogen, an acid neutralizing ion or an esterifying radical; with the proviso that when n is 2 and E is oxygen, A is other than phenyl or substituted phenyl. These chemical intermediates are useful in the preparation of oxazepinones, thiazepinones and diazepinones which exhibit antihistaminic activity.

  化学中间体的化学式为：##STR1## 其中A代表苯、萘、喹啉或吡啶中的任意一个芳香或杂环环系，在任何四个位置上选择，任何一个环系都可以选择由卤、低烷基、低烷氧基、二低烷基氨基、硝基或三氟甲基中的一个或两个Y基团取代；R选自低烷基、环烷基或苯基低烷基，其中苯基可以选择由卤、低烷基、低烷氧基、硝基或三氟甲基中的一个或两个基团取代；R.sup.4和R.sup.5选自氢或低烷基；n为1或2；X选择氯、溴或氟，E选择硫、氧或##STR2## 化学中间体的化学式为：##STR3## 其中A、R、R.sup.4、R.sup.5、E和n的定义如上所述，Q选择##STR4## 其中R.sup.3为氢、酸中和离子或酯化基团；但当n为2且E为氧时，A不是苯或取代苯。这些化学中间体在制备具有抗组胺活性的噁唑烷酮、噻唑烷酮和二嗪烷酮方面非常有用。
• Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid
  申请人：A. H. Robins Company, Incorporated

  公开号：US04810795A1

  公开（公告）日：1989-03-07

  Aromatic azepinones and thiones having the formula ##STR1## wherein; A is benzene, naphthalene, quinoline or pyridine; B is oxygen or sulfur; ##STR2## E is oxygen, sulfur or n is 1, 2 or 3; Z is an amino or a heterocyclic nitrogen-containing radical; R is hydrogen, loweralkyl, cycloalkyl or phenyl-loweralkyl; Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracetylamino, trifluoromethyl, phenyl or phenyl substituted by one to three Y' radicals selected from halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracylamino or trifluoromethyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.

  公开了具有以下公式的芳香族氮杂七元酮和硫酮：##STR1## 其中；A为苯，萘，喹啉或吡啶；B为氧或硫；##STR2## E为氧，硫或n为1、2或3；Z为氨基或含氮杂环的杂环基；R为氢，低烷基，环烷基或苯基-低烷基；Y为卤素，低烷基，低烷氧基，二低烷基氨基，硝基，氨基，低乙酰氨基，三氟甲基，苯基或由一到三个Y'基选择的卤素，低烷基，低烷氧基，二低烷基氨基，硝基，氨基，低乙酰氨基或三氟甲基取代的苯基；具有抗组胺作用，公开了其制备方法和化学中间体。
• Process for the preparation of methylene derivatives of androsta-1,4-diene 3-17 dione
  申请人：FARMITALIA CARLO ERBA S.r.l.

  公开号：EP0307134A1

  公开（公告）日：1989-03-15

  The invention relates to a new process for the preparation of known aromatase inhibitors of the following formula wherein each of R₁ and R₃, independently, is hydrogen or C₁-C₆ alkyl; R₂ is hydrogen, halogen or C₁-C₆ alkyl and R₄ is hydrogen or fluorine; the process comprising subjecting to Mannich reaction a compound of formula wherein R₁,R₂,R₃ and R₄ are as defined above, and then oxidizing the respective 6-methylene derivative thus obtained.

  本发明涉及一种制备下式已知芳香化酶抑制剂的新工艺 其中 R₁ 和 R₃ 各自独立地为氢或 C₁-C₆ 烷基； R₂ 是氢、卤素或 C₁-C₆ 烷基，以及 R₄ 是氢或氟；该工艺包括将式化合物进行曼尼希反应 式中 R₁、R₂、R₃ 和 R₄ 如上文所定义，然后氧化由此得到的各 6-亚甲基衍生物。
• Fused aromatic oxazepinones and sulphur analogues thereof and their preparation and use in counteracting histamine
  申请人：A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation)

  公开号：EP0107930B1

  公开（公告）日：1990-11-28